Javascript must be enabled to continue!
Elevated lipoprotein(a) level predicts repeated peripheral revascularization
View through CrossRef
Abstract
Background
Despite high-intensity lipid-lowering therapy, there is a residual risk of cardiovascular events that could be associated with lipoprotein(a) [Lp(a)]. Data about the role of Lp(a) in the development of significant stenosis after carotid and lower extremity artery revascularization are lacking.
Purpose
To evaluate the relationship of Lp(a) level with repeated revascularization due to restenosis or de novo stenosis after endovascular or surgery repair of carotid and lower limb arteries.
Methods
The study included 258 patients (209 men and 49 women, mean age 67 years) who underwent revascularization of carotid and/or arteries of lower extremities for symptomatic stenotic atherosclerosis. Restenosis or de novo stenosis has been assessed by ultrasonography or angiography. History and physical examination have been performed to identify atherosclerosis risk factors. Lipids, C-reactive protein, Lp(a) concentrations were measured in blood serum.
Results
During 3 years follow-up, repeated revascularization due to restenosis or de novo stenosis was registered in 111 patients. Hyperlipoproteinemia(a) [Lp(a) ≥30 mg/dL] was associated with an increased risk of repeated revascularization with hazard ratio 2.9; 95% confidence interval 2.0–4.2, p<0.01 (figure). C-reactive protein and other clinical and laboratory variables did not differ in patients with and without repeated peripheral revascularization. According to Cox regression analysis adjusted for all risk factors, hyperlipoproteinemia(a) remained an independent predictor of severe restenosis or de novo stenosis of carotid and lower extremity arteries and was associated with a threefold increased risk of repeated revascularization.
Conclusions
In a three-year prospective study of patients after peripheral revascularization, Lp(a) level ≥30 mg/dL was shown as an independent risk factor for repeated revascularization.
Funding Acknowledgement
Type of funding sources: None. Survival analysis
Oxford University Press (OUP)
Title: Elevated lipoprotein(a) level predicts repeated peripheral revascularization
Description:
Abstract
Background
Despite high-intensity lipid-lowering therapy, there is a residual risk of cardiovascular events that could be associated with lipoprotein(a) [Lp(a)].
Data about the role of Lp(a) in the development of significant stenosis after carotid and lower extremity artery revascularization are lacking.
Purpose
To evaluate the relationship of Lp(a) level with repeated revascularization due to restenosis or de novo stenosis after endovascular or surgery repair of carotid and lower limb arteries.
Methods
The study included 258 patients (209 men and 49 women, mean age 67 years) who underwent revascularization of carotid and/or arteries of lower extremities for symptomatic stenotic atherosclerosis.
Restenosis or de novo stenosis has been assessed by ultrasonography or angiography.
History and physical examination have been performed to identify atherosclerosis risk factors.
Lipids, C-reactive protein, Lp(a) concentrations were measured in blood serum.
Results
During 3 years follow-up, repeated revascularization due to restenosis or de novo stenosis was registered in 111 patients.
Hyperlipoproteinemia(a) [Lp(a) ≥30 mg/dL] was associated with an increased risk of repeated revascularization with hazard ratio 2.
9; 95% confidence interval 2.
0–4.
2, p<0.
01 (figure).
C-reactive protein and other clinical and laboratory variables did not differ in patients with and without repeated peripheral revascularization.
According to Cox regression analysis adjusted for all risk factors, hyperlipoproteinemia(a) remained an independent predictor of severe restenosis or de novo stenosis of carotid and lower extremity arteries and was associated with a threefold increased risk of repeated revascularization.
Conclusions
In a three-year prospective study of patients after peripheral revascularization, Lp(a) level ≥30 mg/dL was shown as an independent risk factor for repeated revascularization.
Funding Acknowledgement
Type of funding sources: None.
Survival analysis.
Related Results
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Ischemia-Guided Coronary Revascularization Following Lower-Extremity Revascularization Improves 5-Year Survival of Patients With Chronic Limb-Threatening Ischemia
Ischemia-Guided Coronary Revascularization Following Lower-Extremity Revascularization Improves 5-Year Survival of Patients With Chronic Limb-Threatening Ischemia
Purpose:
To determine whether diagnosis of asymptomatic (silent) coronary ischemia using coronary computed tomography (CT)-derived fracti...
Renal Lipoprotein (a) Metabolism
Renal Lipoprotein (a) Metabolism
The kidney plays a central role in lipoprotein(a) catabolism, acting as a “cemetery for lipoprotein(a)” through uptake, fragmentation, and excretion.
Direct human evidence comes fr...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
Background: Despite high-intensity lipid-lowering therapy, there is a residual risk of cardiovascular events that could be associated with lipoprotein(a) (Lp(a)). It has been shown...
P5503Long term prosnoctic benefit of complete revascularizaction in elderly non ST elevation myocardial infarction patients
P5503Long term prosnoctic benefit of complete revascularizaction in elderly non ST elevation myocardial infarction patients
Abstract
Background
The benefit of complete or culprit vessel revascularization in elderly patients (>75 years) with Acute Co...
Endovascular versus open revascularization for acute arterial occlusive mesenteric ischemia: a retrospective single center analysis
Endovascular versus open revascularization for acute arterial occlusive mesenteric ischemia: a retrospective single center analysis
Abstract
Purpose
Acute arterial occlusive mesenteric ischemia (AAOMI) is a life-threatening emergency associated with hig...
4078Lipoprotein(a) and clinical outcomes in patients after revascularization of peripheral arteries
4078Lipoprotein(a) and clinical outcomes in patients after revascularization of peripheral arteries
Abstract
Background
Randomized trials have proved the reduction of cardiovascular events due to LDL-cholesterol level decrease. ...

